Nuclear osteopontin-c is a prognostic breast cancer marker

被引:0
|
作者
K Zduniak
P Ziolkowski
C Ahlin
A Agrawal
S Agrawal
C Blomqvist
M-L Fjällskog
G F Weber
机构
[1] Wroclaw Medical University,Department of Pathology
[2] Örebro University Hospital,Department of Oncology
[3] Wroclaw Medical University,Department of General and Oncological Surgery
[4] Oncology and Radiation Sciences,Department of Radiology
[5] Uppsala University,undefined
[6] College of Pharmacy,undefined
[7] University of Cincinnati Academic Health Center,undefined
来源
British Journal of Cancer | 2015年 / 112卷
关键词
biomarker; immunohistochemistry; tissue array; breast cancer; cancer progression; prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:729 / 738
页数:9
相关论文
共 50 条
  • [1] Nuclear osteopontin-c is a prognostic breast cancer marker
    Zduniak, K.
    Ziolkowski, P.
    Ahlin, C.
    Agrawal, A.
    Agrawal, S.
    Blomqvist, C.
    Fjallskog, M-L
    Weber, G. F.
    BRITISH JOURNAL OF CANCER, 2015, 112 (04) : 729 - 738
  • [2] Osteopontin-c is a selective marker of breast cancer
    Mirza, Mana
    Shaughnessy, Elizabeth
    Hurley, John K.
    Vanpatten, Kristie A.
    Pestano, Gary A.
    He, Bin
    Weber, Georg F.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (04) : 889 - 897
  • [3] Osteopontin-c is a selective marker of breast cancer
    Weber, Georg
    Mirza, Mana
    Shaughnessy, Elizabeth
    Hurley, John
    Vanpatten, Kristie
    Pestano, Gary
    CANCER RESEARCH, 2009, 69
  • [4] Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer
    Pang, Hui
    Lu, Hailing
    Song, Hongtao
    Meng, Qingwei
    Zhao, Yanbin
    Liu, Na
    Lan, Fei
    Liu, Ying
    Yan, Suhong
    Dong, Xiaoqun
    Cai, Li
    CANCER EPIDEMIOLOGY, 2013, 37 (06) : 985 - 992
  • [5] Osteopontin and Osteopontin-c Protein and mRNA Expression Correlate with Breast Cancer Aggressiveness
    Peiro, G.
    Ortiz-Martinez, F.
    Lerma, E.
    Adrover, E.
    Planelles, M.
    Sanchez-Tejada, L.
    Aranda, F. I.
    Gutierrez-Avino, F. J.
    Giner, D.
    MODERN PATHOLOGY, 2011, 24 : 57A - 57A
  • [6] Osteopontin and Osteopontin-c Protein and mRNA Expression Correlate with Breast Cancer Aggressiveness
    Peiro, G.
    Ortiz-Martinez, F.
    Lerma, E.
    Adrover, E.
    Planelles, M.
    Sanchez-Tejada, L.
    Aranda, F. L.
    Gutierrez-Avino, F. J.
    Giner, D.
    LABORATORY INVESTIGATION, 2011, 91 : 57A - 57A
  • [7] Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer
    Mattos, Daniella
    Rocha, Murilo
    Tessmann, Josiane
    Ferreira, Luciana
    Gimba, Etel
    DIAGNOSTICS, 2024, 14 (19)
  • [8] Clinical Role of Total Osteopontin and Osteopontin-c mRNA in Subtypes of Breast Carcinoma
    Ortiz-Martinez, F.
    Gutierrez-Avino, F. J.
    Giner, D.
    Ciprian, D.
    Andres, L.
    Adrover, E.
    Aranda, F. I.
    Lerma, E.
    Peiro, G.
    MODERN PATHOLOGY, 2012, 25 : 57A - 57A
  • [9] Clinical Role of Total Osteopontin and Osteopontin-c mRNA in Subtypes of Breast Carcinoma
    Ortiz-Martinez, F.
    Gutierrez-Avino, F. J.
    Giner, D.
    Ciprian, D.
    Andres, L.
    Adrover, E.
    Aranda, F. I.
    Lerma, E.
    Peiro, G.
    LABORATORY INVESTIGATION, 2012, 92 : 57A - 57A
  • [10] The splicing isoform osteopontin-c contributes to ovarian cancer progression
    Tilli, Tatiana M.
    Franco, Vanessa
    Robbs, Bruno
    Wanderley, Joao
    Borges, Fabricio
    Viola, Joao
    Weber, Georg
    Gimba, Etel
    CANCER RESEARCH, 2010, 70